InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kramer Kelly A., Director. Director active across 3 companies, notably Gilead Sciences, INC.. Cumulatively, 6 disclosures have been recorded. The latest transaction was filed on 26 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
US$196,5322,806 shares@ US$70.03990.0001% mcap100.0% of flow
Common Stock
SEC:0001629885-25-000005·
€196,5322,806 shares@ €70.03990.0001% mcap50.0% of flow
Common Stock
SEC:0001629885-25-000005:0·
01,270 shares0
Class A Common Stock
SEC:0001679788-22-000059:0·
09,671 shares0
Class A Common Stock
SEC:0001679788-22-000017:0·
01,224 shares0
Class A Common Stock
SEC:0001640147-21-000166·
01,224 shares0
Class A Common Stock
SEC:0001640147-21-000166:0·
6 of 6 declarations
About Kramer Kelly A.
Kelly A. Kramer is a Director of GILEAD SCIENCES, INC., Snowflake Inc., and Coinbase Global, Inc. She plays a key role in the strategic direction of these companies, ensuring that decisions made align with growth and innovation objectives.
